Skip to main content
SpringerLink
Log in

Clinical outcomes with polypharmacy in RA

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bechman K, et al. Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology : 14 Apr 2019. Available from: URL: http://doi.org/10.1093/rheumatology/kez037

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clinical outcomes with polypharmacy in RA. Reactions Weekly 1750, 8 (2019). https://doi.org/10.1007/s40278-019-60872-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-60872-6

Search

Navigation